Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAVA Cassava Sciences Inc

交易中 11-18 11:19:16 EST

27.42

+0.51

+1.90%

最高27.65	最低26.11	成交量72.91万
今开27.40	昨收26.91	日振幅5.72%
总市值13.19亿	流通市值11.77亿	总股本4,811万
成交额1,966万	换手率1.70%	流通股本4,293万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAVA","market":"US","secType":"STK","nameCN":"Cassava Sciences Inc","latestPrice":27.42,"timestamp":1731946752265,"preClose":26.91,"halted":0,"volume":729118,"delay":0,"floatShares":42925070,"shares":48110475,"eps":-1.37344,"marketStatus":"交易中","marketStatusCode":2,"change":0.51,"latestTime":"11-18 11:19:16 EST","open":27.4,"high":27.65,"low":26.11,"amount":19659932.648174,"amplitude":0.057228,"askPrice":27.47,"askSize":100,"bidPrice":27.39,"bidSize":265,"shortable":3,"etf":0,"ttmEps":-1.37344,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731963600000},"adr":0,"adjPreClose":26.91,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":27.4,"preClose":26.91,"latestTime":"09:29 EST","volume":33689,"amount":926610.959028,"timestamp":1731940184235},"postHourTrading":{"tag":"盘后","latestPrice":27.19,"preClose":26.91,"latestTime":"19:59 EST","volume":25133,"amount":683677.7475,"timestamp":1731718789687},"volumeRatio":1.770824,"impliedVol":4.7642,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/SAVA/tweets","defaultTab":"tweets","newsList":[{"id":"2484261510","title":"木薯科学2024财年第三财季实现净利润-27.94百万美元，同比减少8.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484261510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484261510?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773008,"startTime":"0","endTime":"0","summary":"11月17日，木薯科学公布财报，公告显示公司2024财年第三财季净利润为-27.94百万美元，同比减少8.93%；其中营业收入为0.00美元，每股基本收益为-0.58美元。机构评级：截至2024年11月17日，当前有2家机构对木薯科学目标价做出预测，其中目标均价为111.50美元，其中最低目标价为107.00美元，最高目标价为116.00美元。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000440a23e0729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000440a23e0729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA"],"gpt_icon":0},{"id":"2483004306","title":"木薯科学盘中异动 早盘大幅上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483004306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483004306?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:44","pubTimestamp":1731685460,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时44分，木薯科学股票出现波动，股价快速上涨5.20%。截至发稿，该股报27.50美元/股，成交量49.1349万股，换手率1.02%，振幅7.69%。木薯科学股票所在的生物技术行业中，整体跌幅为3.27%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523442098e42fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523442098e42fe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","BK4588","SAVA","BK4547"],"gpt_icon":0},{"id":"2483800929","title":"木薯科学盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483800929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483800929?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:15","pubTimestamp":1731597316,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时15分，木薯科学股票出现波动，股价快速上涨5.04%。截至发稿，该股报26.45美元/股，成交量28.0543万股，换手率0.58%，振幅3.93%。木薯科学股票所在的生物技术行业中，整体跌幅为0.77%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114231516abc172c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114231516abc172c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","SAVA","BK4007","BK4547","PULM"],"gpt_icon":0},{"id":"2483549188","title":"木薯科学盘中异动 股价大跌5.00%报25.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483549188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483549188?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:49","pubTimestamp":1731527363,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时49分，木薯科学股票出现异动，股价大幅跳水5.00%。截至发稿，该股报25.06美元/股，成交量80.4054万股，换手率1.67%，振幅7.35%。木薯科学股票所在的生物技术行业中，整体跌幅为0.47%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114034923971a65de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114034923971a65de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","BK4547","SAVA","BK4588","BK4585"],"gpt_icon":0},{"id":"1161555207","title":"异动解读 | 阿尔茨海默病新药新技术研发进展备受关注 木薯科学股价大涨9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161555207","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161555207?lang=zh_cn&edition=full","pubTime":"2024-11-11 03:50","pubTimestamp":1731268229,"startTime":"0","endTime":"0","summary":"11月8日,专注于阿尔茨海默病研究的生物科技公司木薯科学盘中股价大涨9.05%,引发市场广泛关注。木薯科学目前正在推动其潜在阿尔茨海默病新药simufilam和早期诊断技术SavaDx的研发进程。消息显示,simufilam正在进行两项关键的III期临床试验,测试其在治疗阿尔茨海默病方面的安全性和疗效。如果临床试验取得积极结果,simufilam有望最终获批上市,为阿尔茨海默病患者带来新的治疗方案。据介绍,SavaDx可通过简单的血液检测,在病症明显出现前数年就发现阿尔茨海默病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAVA"],"gpt_icon":0},{"id":"1128378666","title":"异动解读 | 木薯科学大涨6.76% 市场关注公司临床试验进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1128378666","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128378666?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:46","pubTimestamp":1731095206,"startTime":"0","endTime":"0","summary":"11月8日,治疗阿尔茨海默病的生物技术公司木薯科学股价在盘中飙升6.76%。这一异动引起了市场广泛关注,投资者对公司新药研发进展抱有较高预期。最新资料显示,木薯科学目前正在开展两项关键的III期临床试验,分别测试其研发的新药simufilam用于治疗阿尔茨海默病的安全性和疗效。除simufilam外,木薯科学还研发了另一项名为SavaDx的诊断技术,旨在提早发现阿尔茨海默病的存在。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAVA"],"gpt_icon":0},{"id":"2482432140","title":"木薯科学盘中异动 急速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482432140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482432140?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:43","pubTimestamp":1731095012,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日03时43分，木薯科学股票出现波动，股价急速拉升5.37%。截至发稿，该股报26.70美元/股，成交量90.7687万股，换手率1.89%，振幅7.34%。木薯科学股票所在的生物技术行业中，整体涨幅为1.21%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109034332abaed4b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109034332abaed4b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4585","BK4007","SAVA","BK4588"],"gpt_icon":0},{"id":"1148869362","title":"异动解读 | 生物技术公司Cassava Sciences季报亏损超预期,股价大跌6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148869362","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148869362?lang=zh_cn&edition=full","pubTime":"2024-11-08 14:03","pubTimestamp":1731045813,"startTime":"0","endTime":"0","summary":"生物技术公司Cassava Sciences Inc.今日股价盘中大跌6.36%,报收于25.22美元,这主要是因为该公司于昨日公布的2024财年第三季度财报业绩不佳,季度亏损超过分析师预期所致。财报显示,Cassava Sciences截至9月30日的季度调整后每股亏损0.58美元,高于分析师平均预期的每股亏损0.88美元。Cassava Sciences专注于研发治疗阿尔茨海默病的新药物simufilam和诊断产品SavaDx。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAVA"],"gpt_icon":0},{"id":"1179308254","title":"异动解读 | Cassava Sciences临床药物研发公司财报季亏损超预期 盘中股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1179308254","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179308254?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:33","pubTimestamp":1730993583,"startTime":"0","endTime":"0","summary":"生物技术公司Cassava Sciences Inc今日股价盘中大跌5.08%,引发市场广泛关注。这主要是因为该公司于昨日公布的2024财年第三季度财报表现不佳,季度亏损超出分析师预期所致。财报显示,Cassava Sciences截至9月30日的季度调整后每股亏损0.58美元,高于分析师平均预期的每股亏损0.88美元。全季度亏损2794万美元,收入为零。Cassava Sciences致力于研发治疗阿尔茨海默病新药物simufilam和诊断产品SavaDx。尽管如此,分析机构对该股仍保持积极态度。分析师预期该股未来12个月目标股价中位数为116美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SAVA"],"gpt_icon":0},{"id":"2481182278","title":"木薯科学盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481182278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481182278?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:23","pubTimestamp":1730993035,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时23分，木薯科学股票出现波动，股价大幅下跌5.08%。截至发稿，该股报25.22美元/股，成交量33.0622万股，换手率0.69%，振幅5.80%。木薯科学股票所在的生物技术行业中，整体涨幅为0.05%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723235598e413b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723235598e413b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4547","BK4007","BK4585","SAVA"],"gpt_icon":0},{"id":"2481618563","title":"木薯科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481618563","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481618563?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:29","pubTimestamp":1730989748,"startTime":"0","endTime":"0","summary":"   * Cassava Sciences Inc   报告，截至9月30日的季度调整后每股亏损58美分，高于去年同期的每股-61美分。两位分析师对该季度的平均预期是每股亏损 88 美分。华尔街预期为每股亏损 1.37 美元至-39 美分。* Cassava Sciences Inc 公布的本季度每股收益为亏损 58 美分。* 该公司当季亏损 2794 万美元。* Cassava Sciences Inc 本季度股价下跌了 9.7%，今年迄今为止上涨了 18.0%。华尔街对 Cassava Sciences Inc 的 12 个月目标价中位数为 116.00。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"木薯科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA"],"gpt_icon":0},{"id":"2481604419","title":"Cassava Sciences Inc   预计每股亏损 88 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481604419","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481604419?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:50","pubTimestamp":1730901010,"startTime":"0","endTime":"0","summary":"   * Cassava Sciences Inc    将于11月7日公布截至2024年9月30日的财报，预计季度收入将保持不变。*    * LSEG分析师对Cassava Sciences Inc的平均预期是每股亏损88美分。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细分为 1 个 \"强烈买入 \"或 \"买入\"，1 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Cassava Sciences Inc 的 12 个月目标价中位数为 116.00 美元，高于其最新收盘价 23.93 美元。11月6日 - 本摘要于北京时间 11 月 6 日 13:49 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cassava Sciences Inc   预计每股亏损 88 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA"],"gpt_icon":0},{"id":"2481638990","title":"木薯科学盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481638990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481638990?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:03","pubTimestamp":1730826180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时03分，木薯科学股票出现异动，股价急速下跌5.09%。截至发稿，该股报24.53美元/股，成交量58.3627万股，换手率1.22%，振幅4.28%。木薯科学股票所在的生物技术行业中，整体涨幅为1.21%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106010301971a47b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106010301971a47b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","SAVA","BK4547","BK4585"],"gpt_icon":0},{"id":"2477559682","title":"木薯科学盘中异动 股价大跌5.17%报26.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477559682?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:01","pubTimestamp":1729702915,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时01分，木薯科学股票出现波动，股价急速下挫5.17%。截至发稿，该股报26.96美元/股，成交量69.4186万股，换手率1.45%，振幅5.98%。木薯科学股票所在的生物技术行业中，整体跌幅为1.06%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401015598e3e0b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401015598e3e0b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4007","BK4585","SAVA","BK4588"],"gpt_icon":0},{"id":"2477887233","title":"太极集团(600129.SH)：盐酸羟考酮缓释片获得药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2477887233","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477887233?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:39","pubTimestamp":1729589959,"startTime":"0","endTime":"0","summary":"智通财经APP讯，太极集团 发布公告，近日，公司控股子公司西南药业股份有限公司收到国家药品监督管理局关于盐酸羟考酮缓释片的《药品注册证书》，盐酸羟考酮适用于缓解持续的中度到重度疼痛。按照麻醉药品管理。经《Menet》数据库统计，2023年盐酸羟考酮缓释片在中国城市公立、城市社区、乡镇卫生医院销售总额63452万元。截至目前，西南药业对该产品累计投入研发费用970.45万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","600129","BK0239","BK4007","BK4547","BK0113","SAVA","BK4585"],"gpt_icon":0},{"id":"2476945376","title":"木薯科学盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476945376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476945376?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:03","pubTimestamp":1729094599,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时03分，木薯科学股票出现异动，股价急速上涨5.10%。截至发稿，该股报29.70美元/股，成交量63.3516万股，换手率1.32%，振幅4.95%。木薯科学股票所在的生物技术行业中，整体跌幅为0.43%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017000319971a0abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017000319971a0abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","SAVA","BK4547","BK4585"],"gpt_icon":0},{"id":"2475360092","title":"木薯科学盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475360092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475360092?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:10","pubTimestamp":1728915041,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时10分，木薯科学股票出现波动，股价快速拉升5.00%。截至发稿，该股报27.09美元/股，成交量24.0498万股，换手率0.50%，振幅5.70%。木薯科学股票所在的生物技术行业中，整体跌幅为0.04%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014221041a1e08ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014221041a1e08ea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","BK4585","BK4588","SAVA"],"gpt_icon":0},{"id":"2474143610","title":"木薯科学盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474143610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474143610?lang=zh_cn&edition=full","pubTime":"2024-10-12 00:25","pubTimestamp":1728663914,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日00时25分，木薯科学股票出现异动，股价急速上涨5.03%。截至发稿，该股报26.11美元/股，成交量76.3497万股，换手率1.59%，振幅5.29%。木薯科学股票所在的生物技术行业中，整体涨幅为1.18%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101200251498e3bed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101200251498e3bed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4585","BK4588","BK4547","BK4007"],"gpt_icon":0},{"id":"2474225618","title":"木薯科学盘中异动 早盘大幅跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225618?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:44","pubTimestamp":1728481491,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时44分，木薯科学股票出现波动，股价急速下跌5.05%。截至发稿，该股报24.74美元/股，成交量43.1958万股，换手率0.90%，振幅6.72%。木薯科学股票所在的生物技术行业中，整体跌幅为0.29%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009214452a1df6b78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009214452a1df6b78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","BK4588","BK4139","BK4585","IKT","SAVA"],"gpt_icon":0},{"id":"2473738854","title":"BUZZ-美国证券交易委员会就老年痴呆症药物试验索赔达成和解后，木薯公司业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2473738854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473738854?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:52","pubTimestamp":1728395534,"startTime":"0","endTime":"0","summary":"    10月8日 - ** 药物开发商 Cassava Sciences   股价早盘上涨 8.2%，报 27.49 美元** 公司称决定与美国证券交易委员会达成和解；支付 4000 万美元罚款** 美国证券交易委员会曾指控  SAVA 公司及其两名前高管对一种实验性阿尔茨海默氏症药物的临床试验结果进行误导性宣传。** 表示，证交会的和解使任何可能对股价长期上涨构成重大挑战的争议化为乌有，并将重心转回阿尔茨海默氏症药物研究上** 包括本交易日涨幅在内，该股今年累计上涨 27.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cassavasciences.com","stockEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0918},{"period":"3month","weight":-0.0561},{"period":"6month","weight":0.1639},{"period":"1year","weight":0.2288},{"period":"ytd","weight":0.1955}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cassava Sciences, Inc.是一家致力于开发新药的生物制药企业。公司主要候选药物称为羟考酮 (oxycodone) 缓释胶囊 。羟考酮是功效强大的止痛药，其独特的配方有助于减少非计划用量的潜在威胁。羟考酮和其他三种非滥用止疼药是按照与国王制药股份有限公司（King Pharmaceuticals, Inc.）的合作以及许可证协议（Pfizer Agreements）开发研制的。国王制药股份有限公司是辉瑞制药股份有限公司（Pfizer, Inc.）的子公司。公司于1998年5月在特拉华州注册成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.155421},{"month":2,"riseRate":0.416667,"avgChangeRate":0.028198},{"month":3,"riseRate":0.458333,"avgChangeRate":0.024377},{"month":4,"riseRate":0.583333,"avgChangeRate":0.060573},{"month":5,"riseRate":0.416667,"avgChangeRate":0.028089},{"month":6,"riseRate":0.458333,"avgChangeRate":-0.016342},{"month":7,"riseRate":0.458333,"avgChangeRate":0.000768},{"month":8,"riseRate":0.48,"avgChangeRate":0.013502},{"month":9,"riseRate":0.6,"avgChangeRate":0.108222},{"month":10,"riseRate":0.4,"avgChangeRate":-0.045759},{"month":11,"riseRate":0.64,"avgChangeRate":0.02623},{"month":12,"riseRate":0.375,"avgChangeRate":0.049835}],"exchange":"NASDAQ","name":"Cassava Sciences Inc","nameEN":"Cassava Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cassava Sciences Inc,SAVA,Cassava Sciences Inc股票,Cassava Sciences Inc股票老虎,Cassava Sciences Inc股票老虎国际,Cassava Sciences Inc行情,Cassava Sciences Inc股票行情,Cassava Sciences Inc股价,Cassava Sciences Inc股市,Cassava Sciences Inc股票价格,Cassava Sciences Inc股票交易,Cassava Sciences Inc股票购买,Cassava Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}